Anterix Inc. ATEX
81.42
0.09
0.11%
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 23.2×
Follow ATEX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 27.92% | 43.27% | 42.72% | 50.41% |
+8 more TTM periods Free account |
|
| 15.32% | 22.71% | 21.87% | 25.93% | ||
ROIC |
26.21% | 35.84% | 25.28% | 30.92% | |
Return on Tangible Assets |
53.72% | 106.86% | 543.28% | 379.48% | |
Average Days of Receivables |
739.54 | 597.27 | 535.44 | 465.04 | |
Free Cash Flow per Share |
(1.01) | (1.16) | (2.78) | (2.69) | |
Free Cash Flow |
(19.33) | (21.74) | (51.93) | (50.33) | |
Capital Expenditures |
(30.02) | (27.25) | (25.37) | (24.34) | |
Piotroski F-Score |
5.00 | 5.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
2.66% | 1.53% | (10.01%) | (9.30%) | |
Accounts Receivable Turnover |
0.72 | 0.63 | 0.70 | 0.60 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.10) | (0.05) | (0.05) | (0.06) | |
Research and Development Expense of Revenue |
68.21% | 72.34% | 76.28% | 76.64% | |
Selling, General and Administrative Expense of Revenue |
604.40% | 660.87% | 719.79% | 727.68% | |
Share Based Compensation of Revenue |
158.23% | 176.76% | 197.34% | 208.54% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.16 | 0.06 | (0.33) | (0.27) | |
Depreciation/Fixed assets |
0.58 | 0.56 | 0.47 | 0.47 | |
Capex/Depreciation |
(68.08) | (58.73) | (58.05) | (51.24) | |
Revenue per Share |
0.37 | 0.35 | 0.32 | 0.32 | |
Operating CF per Share |
0.56 | 0.29 | (1.42) | (1.39) | |
Capex per Share |
(1.57) | (1.46) | (1.36) | (1.30) | |
Capex to Sales |
4.26 | 4.19 | 4.28 | 4.11 | |
Net Profit Margin |
933.04% | 1,394.17% | 1,370.92% | 1,614.08% |
Columns are period end dates